Steinbach, SandroDepartment of Agricultural and Resource Economics, University of Connecticut, Storrs, CT 06269, USA - Department of Management, Technology and Economics, ETH Zurich, 8006 Zurich, Switzerland -
Sun, YanDepartment of Biology, University of Fribourg, 1700 Fribourg, Switzerland
Skjøth, Carsten A.School of Science and the Environment, University of Worcester, WorcesterWR2 6AJ, UK
Weger, Letty A. deDepartment of Pulmonology, Leiden University Medical Center, 2300RC Leiden, The Netherlands
Lommen, Suzanne T. E.Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland - Institute of Biology, Leiden University, 2333BE Leiden, The Netherlands
Augustinus, Benno AndreasCABI, 2800 Delémont, Switzerland - Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland
Bonini, MairaAgency for Health Protection of Metropolitan Area of Milan (ATS), 20122 Milano, Italy
Karrer, GerhardInstitute of Botany, University of Natural Resources and Life Sciences, 1180Vie nna, Austria
Šikoparija, BrankoBioSense Institute - Research Institute for Information Technologies in Biosystems, University of Novi Sad, 21101 Novi Sad, Serbia
Thibaudon, MichelFrench Network of Aerobiological Monitoring RNSA, 69690 Brussieu, France
Müller-Schärer, HeinzDepartment of Biology, University of Fribourg, 1700 Fribourg, Switzerland
Nature Communications. - 2020, vol. 11, no. 1, p. 1745
English
Invasive alien species (IAS) can substantially affect ecosystem services and human well-being. However, quantitative assessments of their impact on human health are rare and the benefits of implementing IAS management likely to be underestimated. Here we report the effects of the allergenic plant Ambrosia artemisiifolia on public health in Europe and the potential impact of the accidentally introduced leaf beetle Ophraella communa on the number of patients and healthcare costs. We find that, prior to the establishment of O. communa, some 13.5 million persons suffered from Ambrosia-induced allergies in Europe, causing costs of Euro 7.4 billion annually. Our projections reveal that biological control of A. artemisiifolia will reduce the number of patients by approximately 2.3 million and the health costs by Euro 1.1 billion per year. Our conservative calculations indicate that the currently discussed economic costs of IAS underestimate the real costs and thus also the benefits from biological control.